Skip to main content

InvestorNewsBreaks – TRxADE Health Inc.’s (NASDAQ: MEDS) Merger Partner Unveils Innovative Product It’s Bringing to Multibillion US Snacking Market

Superlatus Inc. recently merged with TRxADE Health (NASDAQ: MEDS) and is gearing up to revolutionize the snack industry. The company today unveiled its intent to introduce pulse-based twisted protein snacks through its Brave Robot brand. This innovation leverages the advanced food extrusion technology from its wholly owned subsidiary Sapientia Technology, LLC. By exploiting the combined power of unique food technology developed by well-known scientist Dr. Gino Bortone, inventor of Cheetos Frito-Lay’s Twisted Cheetos, and leveraging the widespread popularity and distribution of the Brave Robot brand, the company expects to be successful in the snack food sector, projected to be worth a staggering $736 billion by 2026. “Over 100,000 schools and institutions serve school lunches to 29.6 million students daily. We know soft drinks and traditional chips are the most frequent items sold in vending machines at school,” said Superlatus interim CEO Tim Alford. “By dominating and leading the better-for-you (‘BFY’) snack category in the schools, colleges and universities across the continental United States, we have the unique opportunity to grow rapidly as our products have a long shelf-life, no chemicals and there are no freezing costs.”

To view the full press release, visit

About TRxADE Health Inc.

TRxADE Health is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The company operates the TRxADE drug procurement marketplace serving approximately 14,500+ members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient-centric telehealth services. The company plans to exit the health services IT business. For more information on TRxADE Health, visit the company’s IR website at

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.